Announcements
16 July 2026
Cancers | Sarcoma and Bone Cancer Awareness Month
July is designated as Sarcoma and Bone Cancer Awareness Month, a time when global activities aim to increase awareness of sarcoma and bone cancer and support research and development efforts. We would like to take this opportunity to extend our sincere appreciation to all researchers and clinicians who have contributed to advancing our understanding and treatment of sarcoma and bone cancer. In particular, we are pleased to share some of the high-quality and innovative research findings in the field, as published in Cancers (ISSN 2072-6694). We hope this announcement provides useful insights for those working in this area. The list of relevant papers can be found below.
“Gene Expression Profile (GEP) Comparison of Atypical Fibroxanthoma (AFX) and Pleomorphic Dermal Sarcoma (PDS)”
by Alessio Giubellino, Gerardo Cazzato, Mario Della Mura, Giuseppe Broggi, Alessandro Rizzo, Nehaaluddin Azmi, Carlos A. Torres-Cabala, Sarah Munro and Faqian Li
Cancers 2026, 18(6), 934; https://doi.org/10.3390/cancers18060934
“A Systematic Review of Cutaneous Involvement in Metastatic Bone Sarcomas: Insights from 102 Reported Cases”
by Nikolaos Sideris, Efstratios Vakirlis and Elena Sotiriou
Cancers 2026, 18(3), 437; https://doi.org/10.3390/cancers18030437
“First-Line Chemotherapy Regimens for Advanced and Metastatic Leiomyosarcoma: Doxorubicin vs. Gemcitabine—A Systematic Review”
by Ilma Khan, Priyal Agarwal, Nassar El Assaad, Ravin Ratan and Elise F. Nassif Haddad
Cancers 2026, 18(2), 335; https://doi.org/10.3390/cancers18020335
“Classic Kaposi Sarcoma: Current Treatment Strategies and Emerging Therapeutic Approaches”
by Daniela Revenko, Natali Shirron, Reut Shainer, Emily Avitan-Hersh and Alona Zer
Cancers 2026, 18(6), 1008; https://doi.org/10.3390/cancers18061008
“Characterisation of Bespoke Patient-Derived In Vitro Models of Ewing Sarcoma”
by Elizabeth A. Roundhill, Elton J. R. Vasconcelos, John Davies and Susan A. Burchill
Cancers 2026, 18(3), 512; https://doi.org/10.3390/cancers18030512
“From Bench to Bedside: Advancements in Precision Oncology and Drug Discovery for Osteosarcoma”
by Luca Giacchi, Elisa Pucci and Nadia Rucci
Cancers 2026, 18(4), 561; https://doi.org/10.3390/cancers18040561
“Identification and Characterisation of Canine Osteosarcoma Biomarkers and Therapeutic Targets”
by Jorja Jackson-Oxley, Aziza A. Alibhai, Rachel Thompson, Jennifer Lothion-Roy, Simone de Brot, Mark D. Dunning, Jennie N. Jeyapalan, Nigel P. Mongan and Catrin S. Rutland
Cancers 2026, 18(2), 262; https://doi.org/10.3390/cancers18020262
“Correlation Between Molecular Genetic Analysis and Nuclear Pleomorphism in Long-Term Recurrent and Metastatic Chordoma”
by Sarah Rebecca Ullmann, Julian Schreier, Juan Carlos Alberto Uribe Caputi, Marilena Georgiades, Joana Maria Ullmann, Christoph H. Lohmann, Martin Röpke, Denny Schanze, Sabine Franke, Franziska Sabrina Karras et al.
Cancers 2026, 18(6), 898; https://doi.org/10.3390/cancers18060898
“Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma”
by Katie E. Hebron, Patience Odeniyide, Yun Wei, Berkley E. Gryder, Frederic G. Barr, Dana L. Casey, Eleanor Y. Chen, Brian D. Crompton, Filemon S. Dela Cruz, Adam D. Durbin et al.
Cancers 2026, 18(6), 888; https://doi.org/10.3390/cancers18060888
“Clear Cell and Histiocytic/Dendritic Cell Sarcomas: Clinical Outcomes, Molecular Features, and Diagnostic Pitfalls”
by Gabriel Tinoco, Marium Husain, David Liebner, James L. Chen, Swati Satturwar, Hans Iwenofu, Valerie Grignol, Joal Beane, Scott Lenobel, David Konieczkowski et al.
Cancers 2026, 18(4), 641; https://doi.org/10.3390/cancers18040641
|
“Sarcoma Biology and Therapeutics: From Mechanisms to Novel Treatments” |
“Precision Medicine and Emerging Multidisciplinary Treatment Strategies for Bone and Soft Tissue Sarcomas” |
|
|
“Advances in Soft Tissue and Bone Sarcoma” |
